Tech Company Financing Transactions

Aerie Pharmaceuticals Funding Round

On 10/12/2005, Aerie Pharmaceuticals received $21 million in Series A financing from Alta Partners and TPG Capital.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series A

Alta Partners (Lead Investor) (David Mack)

TPG Capital (Geoff Duyk)

Proceeds Purpose
In addition to the initial candidate, Aerie will also pursue development of a proprietary, breakthrough class of glaucoma product that incorporates novel chemistry to improve penetration of drugs into the eye.

Company Information

Company Status
Private & Independent
Mailing Address
4301 Emperor Blvd. 400
Durham, NC 27703
Email Address
Aerie Pharmaceuticals is focused on developing products for the pharmaceutical treatment of glaucoma.
Aerie Pharmaceuticals LinkedIn Company Profile
Social Media
Aerie Pharmaceuticals Company Twitter Account
Company News
Aerie Pharmaceuticals News
Aerie Pharmaceuticals on Facebook
Aerie Pharmaceuticals on YouTube

Management Team

Email & Social
Chief Executive Officer
Vicente Anido
  Vicente Anido LinkedIn Profile  Vicente Anido Twitter Account  Vicente Anido News  Vicente Anido on Facebook
Chief Financial Officer
Richard Rubino
  Richard Rubino LinkedIn Profile  Richard Rubino Twitter Account  Richard Rubino News  Richard Rubino on Facebook
Chief Medical Officer
Richard Lewis
  Richard Lewis LinkedIn Profile  Richard Lewis Twitter Account  Richard Lewis News  Richard Lewis on Facebook
Chief Scientific Officer
Casey Kopczynski
  Casey Kopczynski LinkedIn Profile  Casey Kopczynski Twitter Account  Casey Kopczynski News  Casey Kopczynski on Facebook
Thomas Mitro
  Thomas Mitro LinkedIn Profile  Thomas Mitro Twitter Account  Thomas Mitro News  Thomas Mitro on Facebook
VP - Bus. Development
Craig Skenes
  Craig Skenes LinkedIn Profile  Craig Skenes Twitter Account  Craig Skenes News  Craig Skenes on Facebook
VP - Finance
Christopher Staten
  Christopher Staten LinkedIn Profile  Christopher Staten Twitter Account  Christopher Staten News  Christopher Staten on Facebook
VP - Human Resources
Kathleen McGinley
  Kathleen McGinley LinkedIn Profile  Kathleen McGinley Twitter Account  Kathleen McGinley News  Kathleen McGinley on Facebook
VP - Manufacturing
Kenneth Ruettimann
  Kenneth Ruettimann LinkedIn Profile  Kenneth Ruettimann Twitter Account  Kenneth Ruettimann News  Kenneth Ruettimann on Facebook
VP - R & D
Eric Carlson
  Eric Carlson LinkedIn Profile  Eric Carlson Twitter Account  Eric Carlson News  Eric Carlson on Facebook
VP - Regulatory Affairs
Marvin Garrett
  Marvin Garrett LinkedIn Profile  Marvin Garrett Twitter Account  Marvin Garrett News  Marvin Garrett on Facebook



Browse more venture capital transactions:

Prev: 10/10/2005: GlycoFi venture capital transaction
Next: 10/12/2005: Ophthonix venture capital transaction


Share this article


Where The Data Comes From

We do our best to document every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The information comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary